These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34222123)

  • 1. Immunogenicity of antigens from outer membrane vesicles of
    Rinaldi FM; Gaspar EB; Brito LT; Gaspari E
    Clin Exp Vaccine Res; 2021 May; 10(2):106-122. PubMed ID: 34222123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B.
    de Oliveira Santos FA; Lincopan N; De Gaspari E
    Immunobiology; 2018 Dec; 223(12):750-760. PubMed ID: 30055864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of different routes of immunization using outer membrane vesicles of Neisseria meningitidis B and comparison of two adjuvants.
    Brito LT; Rinaldi FM; Gaspar EB; Correa VA; Gonçalves CA; Portilho AI; Trzewikoswki de Lima G; De Gaspari E
    Vaccine; 2020 Nov; 38(48):7674-7682. PubMed ID: 33082014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response.
    de Almeida AF; De Gaspari E
    Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29293977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory.
    Izeli Portilho A; Araujo Correa V; Dos Santos Cirqueira C; De Gaspari E
    Immunol Invest; 2022 Oct; 51(7):2066-2085. PubMed ID: 35950702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria lactamica antigens complexed with a novel cationic adjuvant.
    Gaspar EB; Rosetti AS; Lincopan N; De Gaspari E
    Hum Vaccin Immunother; 2013 Mar; 9(3):572-81. PubMed ID: 23296384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
    Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid response to SARS-CoV-2 and
    Portilho AI; Hermes Monteiro da Costa H; Grando Guereschi M; Prudencio CR; De Gaspari E
    Hum Vaccin Immunother; 2024 Dec; 20(1):2346963. PubMed ID: 38745461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
    Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of meningococcal B outer membrane vesicles in middle-aged mice.
    Trzewikoswki de Lima G; Rodrigues TS; Portilho AI; Correa VA; Gaspar EB; De Gaspari E
    Pathog Dis; 2020 Jul; 78(5):. PubMed ID: 32639524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from
    Correa VA; Portilho AI; De Gaspari E
    Diseases; 2022 Jul; 10(3):. PubMed ID: 35892740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System.
    Hekmat S; Sadat SM; Aslani MM; Mahdavi M; Bolhassani A; Asgar Halvaee F; Ghahari SMM; Aghasadeghi MR; Siadat SD
    Iran Biomed J; 2019 Jul; 23(4):235-45. PubMed ID: 30278608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe A; Halliwell D; Matheson M; Reddin K; Finney M; Hudson M
    Vaccine; 2005 Mar; 23(17-18):2210-3. PubMed ID: 15755597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity with Brazilian strains of
    Trzewikoswki de Lima G; Portilho AI; De Gaspari E
    Ther Adv Vaccines Immunother; 2019; 7():2515135519894825. PubMed ID: 31853514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica.
    Kremastinou J; Tzanakaki G; Pagalis A; Theodondou M; Weir DM; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 May; 24(1):73-8. PubMed ID: 10340715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal-fetal transference of antibodies in mice.
    Lima GG; Portilho AI; De Gaspari E
    Pathog Dis; 2022 Oct; 80(1):. PubMed ID: 36220147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
    Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
    Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.
    Zhu D; Zhang Y; Barniak V; Bernfield L; Howell A; Zlotnick G
    Infect Immun; 2005 Oct; 73(10):6838-45. PubMed ID: 16177362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.